Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Neural Therapeutics Inc. ( (TSE:NURL) ) has provided an announcement.
Neural Therapeutics’ portfolio company CWE European Holdings, operating as Hanf.com, has begun sales of Ritual Herbs’ nicotine- and tobacco-free herbal smoking blends in Germany after receiving first commercial shipments, leveraging its exclusive national distribution rights and growing omnichannel retail, e-commerce and wholesale network. The move positions Hanf.com to tap into a rapidly expanding European market for nicotine-free herbal cigarettes and a rising base of cannabis consumers who predominantly smoke, offering Ritual Herbs as a wellness-oriented tobacco substitute and potential cannabis base material, thereby strengthening Hanf.com’s role as an infrastructure partner in Germany’s legal CBD and cannabis market and enhancing Neural’s broader strategic foothold in the region.
More about Neural Therapeutics Inc.
Neural Therapeutics Inc. is an ethnobotanical drug discovery company developing therapeutic drugs for mental health conditions related to substance use disorders, including alcohol and opioid dependence, using sub-hallucinogenic doses of mescaline extract to balance safety, scalability and efficacy. Through a strategic, multi-stage investment in CWE European Holdings Inc., which operates as Hanf.com, one of Germany’s leading CBD and hemp retailers, Neural is expanding its commercial footprint in Europe while maintaining its core focus on mental health innovation.
Average Trading Volume: 283,230
Technical Sentiment Signal: Strong Sell
Current Market Cap: C$2.53M
Learn more about NURL stock on TipRanks’ Stock Analysis page.